6CM
PMN icon

683 Capital Management’s ProMIS Neurosciences PMN Stock Holding History

683 Capital Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Buy
+92,850
New +$1.38M 0.06% 133

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM

683 Capital Management's PMN Position: Q1 2026 in Review

683 Capital Management opened a new position in ProMIS Neurosciences (PMN) in Q1 2026: 92,850 shares worth $1.18M. The stake represents 0.06% of the portfolio and ranks #133 among its holdings.

25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • 683 Capital Management held 92,850 shares of ProMIS Neurosciences worth $1.18M as of Q1 2026.
  • ProMIS Neurosciences was a new 683 Capital Management position in Q1 2026.
  • ProMIS Neurosciences made up 0.06% of 683 Capital Management's portfolio in Q1 2026, its #133 holding.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.